» Articles » PMID: 6234799

Hypertension and Sudden Death. Increased Ventricular Ectopic Activity in Left Ventricular Hypertrophy

Overview
Journal Am J Med
Specialty General Medicine
Date 1984 Jul 1
PMID 6234799
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

The present study was designed to detect and quantify cardiac arrhythmias in hypertensive patients with left ventricular hypertrophy. Continuous ambulatory electrocardiographic tracings and arterial pressure were recorded for 24 hours in 14 normotensive subjects, 10 patients with established essential hypertension without left ventricular hypertrophy, and 16 hypertensive patients with left ventricular hypertrophy by electrocardiographic criteria. Urinary excretion of norepinephrine was simultaneously measured over four successive four-hour and one eight-hour period. Patients with left ventricular hypertrophy had significantly more ventricular (but not atrial) premature contractions than those without left ventricular hypertrophy or than normotensive subjects. Five patients with left ventricular hypertrophy had episodes of more than 30 premature ventricular contractions per minute. Higher-grade ventricular ectopic activity such as coupled premature ventricular contractions was seen in two, and multifocal premature ventricular contractions were seen in three in the group with left ventricular hypertrophy. No difference in urinary catecholamine excretion rates among the three groups was seen. Left ventricular hypertrophy has been shown to be an independent risk factor for sudden death and acute myocardial infarction. Electrocardiographic monitoring of patients with left ventricular hypertrophy allows identification of those who have the highest risk and, therefore, require the most aggressive therapeutic intervention.

Citing Articles

Impact of left ventricular hypertrophy on frequency and complexity of ventricular arrhythmia among hypertensive Egyptian patients.

Abd El Azeem A, Abd Elmoneim M, Rafla S, Youssif G Egypt Heart J. 2024; 76(1):37.

PMID: 38530546 PMC: 10965840. DOI: 10.1186/s43044-024-00472-8.


Left ventricular hypertrophy is independently associated with all-cause mortality.

Movahed M, Ramaraj R, Manrique C, Hashemzadeh M Am J Cardiovasc Dis. 2022; 12(1):38-41.

PMID: 35291507 PMC: 8918741.


Certain beta blockers (e.g., bisoprolol) may be reevaluated in hypertension guidelines for patients with left ventricular hypertrophy to diminish the ventricular arrhythmic risk.

Koracevic G, Stojanovic M, Lovic D, Zdravkovic M, Sakac D J Hum Hypertens. 2021; 35(7):564-576.

PMID: 33654234 DOI: 10.1038/s41371-021-00505-8.


Telmisartan suppresses cardiomyocyte and alveolar wall hypertrophy by the PPARγ-ERK-NFAT complex by changing the balance of PPARγ and ERK.

Ma C, Pu Y, Xue H, Liu Y Int J Clin Exp Pathol. 2020; 12(9):3235-3246.

PMID: 31934167 PMC: 6949821.


Chronic enalapril treatment increases transient outward potassium current in cardiomyocytes isolated from right ventricle of spontaneously hypertensive rats.

Rodrigues Junior L, Carvalho A, Pimentel E, Mill J, Nascimento J Naunyn Schmiedebergs Arch Pharmacol. 2016; 390(3):225-234.

PMID: 27915452 DOI: 10.1007/s00210-016-1322-7.